The global conversation around GLP-1 therapies is evolving rapidly. From R&D shifts to manufacturing and delivery challenges, this space is entering a new phase.
At Pharma Industrial India, I’m currently working on a story capturing industry perspectives on where GLP-1 is headed next.
If you’re working in this space and would like to share your insights with us, I’d be glad to connect.
📩 Feel free to drop me an email on [email redacted] or DM me here on LinkedIn.
Thanks!
Pharma Industrial India
Brought to you by Sourcee
We find journo requests from across the web and deliver them directly to your inbox.